Voyager Therapeutics, Inc. Contracts & Agreements

First Amendment to Option and License Agreement, by and between Registrant and AstraZeneca Ireland Limited, dated September 30, 2024 (Filed With SEC on November 12, 2024)

First Amendment to Option and License Agreement, by and between Registrant and Novartis Pharma AG, dated September 3, 2024 (Filed With SEC on November 12, 2024)

First Amendment to Collaboration Agreement, by and between Registrant and Neurocrine Biosciences, Inc., dated April 3, 2024 (Filed With SEC on August 6, 2024)

Employment Agreement, by and between Voyager Therapeutics, Inc. and Nathan Jorgensen, Ph.D., M.B.A., effective as of July 8, 2024 (Filed With SEC on June 13, 2024)

Amendment No. 4 to Consulting Agreement by and between the Registrant and Dinah Sah, Ph.D., dated as of February 1, 2024 (Filed With SEC on May 13, 2024)

Consulting Agreement by and between the Registrant and Peter P. Pfreundschuh, dated as of May 6, 2024 (Filed With SEC on May 13, 2024)

Transition, Separation and Release of Claims Agreement, by and between the Company and Peter P. Pfreundschuh, dated April 1, 2024 (Filed With SEC on April 2, 2024)

Employment Agreement, by and between Voyager Therapeutics, Inc. and Toby Ferguson, M.D., Ph.D., dated as of February 29, 2024 (Filed With SEC on March 13, 2024)

License and Collaboration Agreement by and between Registrant and Novartis Pharma AG, dated December 28, 2023 (Filed With SEC on February 28, 2024)

Stock Purchase Agreement by and between Registrant and Novartis Pharma AG, dated December 28, 2023 (Filed With SEC on February 28, 2024)

Investor Agreement by and between Registrant and Novartis Pharma AG, dated December 28, 2023 (Filed With SEC on February 28, 2024)

Amendment No. 2 to the Consulting Agreement, by and between the Registrant and Dinah Sah, Ph.D., dated June 27, 2022 (Filed With SEC on February 28, 2024)

Amendment No. 3 to the Consulting Agreement, by and between the Registrant and Dinah Sah, Ph.D., dated May 1, 2023 (Filed With SEC on February 28, 2024)

Underwriting Agreement, dated January 4, 2024, by and among Voyager Therapeutics, Inc. and Citigroup Global Markets Inc. and Guggenheim Securities, LLC, as representatives of the... (Filed With SEC on January 8, 2024)

Form of Pre-Funded Warrant (Filed With SEC on January 8, 2024)

First Amendment to Lease Agreement, by and between Voyager Therapeutics, Inc. and LS 75 Hayden, LLC, dated August 11, 2023 (Filed With SEC on August 16, 2023)

Employment Agreement, by and between Voyager Therapeutics, Inc. and Jacquelyn Fahey Sandell, effective as of July 5, 2023 (Filed With SEC on July 10, 2023)

Consulting Agreement, by and between the Registrant and Robert W. Hesslein, dated April 28, 2023 (Filed With SEC on May 9, 2023)

Amended and Restated Investor Agreement by and between the Registrant and Neurocrine Biosciences, Inc., dated as of January 8, 2023 (Filed With SEC on March 7, 2023)

Stock Purchase Agreement by and between the Registrant and Neurocrine Biosciences, Inc., dated as of January 8, 2023 (Filed With SEC on March 7, 2023)

Patent and Know-How Licence between the Registrant and Touchlight IP Limited, dated as of November 3, 2022 (Filed With SEC on March 7, 2023)

Option and License Agreement by and between the Registrant and Novartis Pharma AG, dated March 4, 2022 (Filed With SEC on March 7, 2023)

Collaboration and License Agreement by and between the Registrant and Neurocrine Biosciences, Inc., dated as of January 8, 2023 (Filed With SEC on March 7, 2023)

Transition, Separation and Release of Claims Agreement, by and between the Company and Robert W. Hesslein, dated February 22, 2023 (Filed With SEC on February 23, 2023)

Employment Agreement, by and between Voyager Therapeutics, Inc. and Peter Pfreundschuh, effective as of September 7, 2022 (Filed With SEC on September 7, 2022)

Employment Agreement, by and between Voyager Therapeutics, Inc. and Todd Carter, Ph.D., effective as of September 7, 2022 (Filed With SEC on September 7, 2022)

Lease Termination Agreement by and between Voyager Therapeutics, Inc. and BRE-BMR Pilgrim & Sidney LLC, dated as of June 22, 2022 (Filed With SEC on June 23, 2022)

Sublease Termination Agreement by and between Voyager Therapeutics, Inc. and BioNTech US Inc., dated as of June 22, 2022 (Filed With SEC on June 23, 2022)

Consulting Agreement by and between Voyager Therapeutics, Inc. and Glenn Pierce, M.D., Ph.D., effective as of June 6, 2022 (Filed With SEC on June 7, 2022)

Option and License Agreement by and between the Registrant and Novartis Pharma AG, dated March 4, 2022 (Filed With SEC on May 4, 2022)

Employment Agreement, by and between Voyager Therapeutics, Inc. and Alfred Sandrock, M.D., Ph.D., effective as of March 22, 2022 (Filed With SEC on March 22, 2022)

Separation and Release of Claims Agreement by and between the Registrant and Allison Dorval, effective December 13, 2021 (Filed With SEC on March 8, 2022)

Consulting Agreement by and between the Registrant and Allison Dorval, dated as of November 26, 2021 (Filed With SEC on March 8, 2022)

Employment Agreement, by and between the Registrant and Julie Burek, dated as of October 1, 2021 (Filed With SEC on March 8, 2022)

Amended and Restated Employment Agreement, by and between Voyager Therapeutics, Inc. and Robin Swartz, effective as of February 7, 2022 (Filed With SEC on February 3, 2022)

Consulting Agreement by and between Voyager Therapeutics, Inc. and Alfred Sandrock, effective as of February 7, 2022 (Filed With SEC on February 3, 2022)

Sublease Agreement, by and between Registrant and BioNTech US Inc., dated September 3, 2021 (Filed With SEC on November 2, 2021)

Option and License Agreement, by and between the Registrant and Pfizer Inc., dated October 1, 2021 (Filed With SEC on November 2, 2021)

Amendment No. 1 to Employment Agreement, by and between the Registrant and Glenn Pierce, dated June 7, 2021 (Filed With SEC on June 8, 2021)

Employment Agreement, by and between the Registrant and Glenn Pierce, M.D., Ph.D., dated May 19, 2021 (Filed With SEC on May 19, 2021)

Employment Agreement, by and between the Registrant and Michael Higgins, dated May 19, 2021 (Filed With SEC on May 19, 2021)

Transition, Separation and Release of Claims Agreement, by and between the Registrant and G. Andre Turenne, dated May 19, 2021 (Filed With SEC on May 19, 2021)

AMENDMENT NO. 2 TO CONSULTING AGREEMENT (Filed With SEC on February 25, 2021)

First Amendment to Amended and Restated Option and License Agreement with Genzyme Corporation, dated September 20, 2020 (Filed With SEC on November 9, 2020)

Lease Agreement, by and between the Registrant and HCP/King 75 Hayden LLC, dated March 16, 2020 (Filed With SEC on March 19, 2020)

Description of Registrants Securities (Filed With SEC on March 3, 2020)

Transition, Separation, and Release of Claims Agreement, by and between the Company and Matthew P. Ottmer, dated as of February 12, 2020 (Filed With SEC on February 14, 2020)

Amendment No. 1 to Consulting Agreement, by and between the Corporation and Dinah Sah, dated September 16, 2019 (Filed With SEC on November 6, 2019)

Amendment No. 1 to Consulting Agreement, by and between the Corporation and Steven M. Paul, M.D., dated July 9, 2019 (Filed With SEC on November 6, 2019)

Consulting Agreement, by and between Voyager Therapeutics, Inc. and Dinah Sah, Ph.D., dated June 28, 2019 (Filed With SEC on August 9, 2019)

Amendment No. 1 to the Collaboration and License Agreement, by and between Voyager Therapeutics, Inc. and Neurocrine Biosciences, Inc., dated June 14, 2019 (Filed With SEC on August 9, 2019)

Amended and Restated Option and License Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019 (Filed With SEC on August 9, 2019)

Termination Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019 (Filed With SEC on August 9, 2019)

Employment Agreement, by and between Voyager Therapeutics, Inc. and Omar Khwaja, M.D., Ph.D, dated May 20, 2019 (Filed With SEC on August 9, 2019)

Retirement Agreement, by and between the Company and Dinah Sah, dated as of May 20, 2019 (Filed With SEC on May 21, 2019)

Employment Agreement, by and between the Registrant and Robert W. Hesslein, dated January 15, 2019 (Filed With SEC on May 7, 2019)

Form of Non-Qualified Stock Option Agreement for Inducement Grant (Filed With SEC on February 26, 2019)

Non-Qualified Stock Option Agreement, by and between Voyager Therapeutics, Inc. and G. Andre Turenne, dated as of July 16, 2018 (Filed With SEC on November 7, 2018)

Employment Agreement, by and between Voyager Therapeutics, Inc. and Allison Dorval, dated November 7, 2018 (Filed With SEC on November 7, 2018)

Consulting Agreement, by and between Voyager Therapeutics, Inc. and Steven M. Paul, M.D., dated August 2, 2018 (Filed With SEC on August 7, 2018)

Retirement Agreement, by and between Voyager Therapeutics, Inc. and Steven M. Paul, dated as of June 28, 2018 (Filed With SEC on June 29, 2018)

Employment Agreement, by and between Voyager Therapeutics, Inc. and G. Andre Turenne, dated as of June 28, 2018 (Filed With SEC on June 29, 2018)

Third Amendment to Lease Agreement, by and between Voyager Therapeutics, Inc. and UP 45/75 Sidney Street, LLC, dated June 1, 2018 (Filed With SEC on June 5, 2018)

First Amendment to Lease Agreement, by and between Voyager Therapeutics, Inc. and UP 64 Sidney Street, LLC, dated June 1, 2018 (Filed With SEC on June 5, 2018)

Specimen Common Stock Certificate of the Registrant (Filed With SEC on March 14, 2018)

Amendment No. 1 to 2015 Employee Stock Purchase Plan (Filed With SEC on March 14, 2018)

Second Amendment to Lease, by and between Voyager Therapeutics, Inc. and UP 45/75 Sidney Street, LLC, dated February 5, 2018 (Filed With SEC on February 7, 2018)

Underwriting Agreement, dated November 7, 2017, by and among Voyager Therapeutics, Inc. and Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the... (Filed With SEC on November 8, 2017)

Employment Agreement, effective September 11, 2017, between the Registrant and Matthew Ottmer (Filed With SEC on September 18, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on January 3, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on May 12, 2016)

FIRST AMENDMENT TO LEASE AGREEMENT (Filed With SEC on May 12, 2016)

VOYAGER THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT APRIL 10, 2015 (Filed With SEC on October 28, 2015)

[] Voyager Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 28, 2015)

VOYAGER THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on October 28, 2015)

VOYAGER THERAPEUTICS, INC. FORM OF OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on October 28, 2015)

VOYAGER THERAPEUTICS, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENT (Filed With SEC on October 28, 2015)

LEASE 45/75 Sidney Street Cambridge, Massachusetts LANDLORD UP 45/75 SIDNEY STREET, LLC TENANT VOYAGER THERAPEUTICS, INC. (Filed With SEC on October 28, 2015)

VOYAGER THERAPEUTICS, INC. 2015 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on October 28, 2015)

VOYAGER THERAPEUTICS, INC. 2014 STOCK OPTION AND GRANT PLAN (Filed With SEC on October 28, 2015)

Category

Industry

Companies

Contracts

Voyager Therapeutics, Inc. Contracts & Agreements